-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guocai has carried out six batches, but so far there is no analysis of the results from authoritative institutions
The price of the selected generic drugs has been exchanged for volume, and the volume and price of the unselected generic drugs have fallen.
Change in sales
Change in salesCompared with one year ago, the procurement volume of the 9 varieties after centralized procurement has increased (2.
1.
The purchase volume of the 9 selected generic drugs increased from 4.
Among them, omeprazole increased the most, from 460 million tablets a year ago to 2.
2.
The purchase volume of 9 unselected original research drugs dropped by 46%
3.
The purchase volume of 9 unselected generic drugs dropped by as much as 81%
Changes in the proportion of sales
Changes in the proportion of salesOne year after the centralized procurement, the proportion of the procurement of various varieties in the total procurement of the generic name has also changed significantly.
The proportion of selected generic drug purchases increased by 53%.
The proportion of purchases of unselected original research drugs decreased by 16%.
The proportion of unselected generic drug purchases decreased by 37%, the largest decrease was omeprazole, which decreased by 69%, and the smallest decrease was imatinib, which decreased by only 2.
price change
price changeOverall, under the same generic name, the average price of 9 drugs decreased significantly, with an average decrease of 67.
As far as a single variety is concerned, the price of only one variety has increased (that is, the unselected generic drug omeprazole has increased by 58%), and all the others have declined regardless of whether they are selected or not.
1.
Selected generic drugs
The average purchase price of the selected generic drugs decreased by 82%.
Among them, the largest decrease was entecavir, which decreased by 90%, and the smallest decrease was imatinib, which only decreased by 22%
.
2.
The original research drug was not selected
The average purchase price of unselected original research drugs decreased by 13%.
Among them, the largest decrease was valsartan, which decreased by 21%, and the smallest decrease was aluminum magnesium carbonate chewable tablets, which only decreased by 6.
5%
.
3.
Unselected generic drugs
The average purchase price of unselected generic drugs decreased by 34% for entecavir, and the smallest decrease was also for aluminum magnesium carbonate chewable tablets, which decreased by only 3.
4%
.
The purchase price of omeprazole that was not selected was the only one that did not drop but increased, and the increase was as high as 58%
.
(Picture 3)
One year after the centralized procurement of 9 drugs, compared with one year before the centralized procurement, the patent cliff appeared, and the substitution of generic drugs was realized.
The constraints of the centralized procurement contract ensured a substantial increase in the procurement of selected generic drugs.
Some companies maintain prices to a certain extent, so that the unselected varieties can temporarily maintain relatively high prices
.
In short, the selected generic drugs have realized the exchange of price for the quantity, while the quantity and price of the unselected varieties have fallen.
Once the price linkage is enforced, the remaining price advantage of the unselected varieties will no longer exist
.